196 related articles for article (PubMed ID: 23374359)
1. Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection.
Taner T; Atwell TD; Zhang L; Oberg TN; Harmsen WS; Slettedahl SW; Kendrick ML; Nagorney DM; Que FG
HPB (Oxford); 2013 Mar; 15(3):190-5. PubMed ID: 23374359
[TBL] [Abstract][Full Text] [Related]
2. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival.
Mazzaglia PJ; Berber E; Milas M; Siperstein AE
Surgery; 2007 Jul; 142(1):10-9. PubMed ID: 17629995
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation for neuroendocrine liver metastases: a systematic review.
Mohan H; Nicholson P; Winter DC; O'Shea D; O'Toole D; Geoghegan J; Maguire D; Hoti E; Traynor O; Cantwell CP
J Vasc Interv Radiol; 2015 Jul; 26(7):935-942.e1. PubMed ID: 25840836
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival after surgical management of neuroendocrine hepatic metastases.
Glazer ES; Tseng JF; Al-Refaie W; Solorzano CC; Liu P; Willborn KA; Abdalla EK; Vauthey JN; Curley SA
HPB (Oxford); 2010 Aug; 12(6):427-33. PubMed ID: 20662794
[TBL] [Abstract][Full Text] [Related]
6. Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.
Galleberg RB; Knigge U; Tiensuu Janson E; Vestermark LW; Haugvik SP; Ladekarl M; Langer SW; Grønbæk H; Österlund P; Hjortland GO; Assmus J; Tang L; Perren A; Sorbye H
Eur J Surg Oncol; 2017 Sep; 43(9):1682-1689. PubMed ID: 28522174
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of laparoscopic tumor ablation for neuroendocrine liver metastases: a 20-year experience.
Kose E; Kahramangil B; Aydin H; Donmez M; Takahashi H; Aucejo F; Siperstein A; Berber E
Surg Endosc; 2020 Jan; 34(1):249-256. PubMed ID: 30945061
[TBL] [Abstract][Full Text] [Related]
8. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy.
Sofocleous CT; Petre EN; Gonen M; Brown KT; Solomon SB; Covey AM; Alago W; Brody LA; Thornton RH; D'Angelica M; Fong Y; Kemeny NE
J Vasc Interv Radiol; 2011 Jun; 22(6):755-61. PubMed ID: 21514841
[TBL] [Abstract][Full Text] [Related]
9. Surgical strategy for liver metastases of neuroendocrine tumors.
Tsuchikawa T; Hirano S; Tanaka E; Kato K; Matsumoto J; Nakayama T; Tabata Y; Shichinohe T
Hepatogastroenterology; 2012 May; 59(115):921-3. PubMed ID: 22024223
[TBL] [Abstract][Full Text] [Related]
10. Repeat hepatic resection in patients with colorectal liver metastases.
Lee H; Choi SH; Cho YB; Yun SH; Kim HC; Lee WY; Heo JS; Choi DW; Jung KU; Chun HK
World J Gastroenterol; 2015 Feb; 21(7):2124-30. PubMed ID: 25717247
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
[TBL] [Abstract][Full Text] [Related]
12. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate.
Andreou A; Brouquet A; Abdalla EK; Aloia TA; Curley SA; Vauthey JN
HPB (Oxford); 2011 Nov; 13(11):774-82. PubMed ID: 21999590
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.
Park JB; Kim YH; Kim J; Chang HM; Kim TW; Kim SC; Kim PN; Han DJ
J Vasc Interv Radiol; 2012 May; 23(5):635-41. PubMed ID: 22525021
[TBL] [Abstract][Full Text] [Related]
14. Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision making.
Bertani E; Falconi M; Grana C; Botteri E; Chiappa A; Misitano P; Spada F; Ravizza D; Bazolli B; Fazio N
Int J Surg; 2015 Aug; 20():58-64. PubMed ID: 26074290
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary treatment strategy for advanced pancreatic neuroendocrine tumors- a single center experience.
Tsuchikawa T; Hirano S; Tanaka E; Kato K; Matsumoto J; Sichinohe T
Hepatogastroenterology; 2012; 59(120):2623-6. PubMed ID: 22497945
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation.
Facciorusso A; Del Prete V; Muscatiello N; Crucinio N; Barone M
J Gastroenterol Hepatol; 2016 Aug; 31(8):1483-8. PubMed ID: 26896637
[TBL] [Abstract][Full Text] [Related]
17. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R
Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858
[TBL] [Abstract][Full Text] [Related]
18. Synchronous resection of primary and liver metastases for neuroendocrine tumors.
Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y
Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376
[TBL] [Abstract][Full Text] [Related]
19. Outcome after resection and radiofrequency ablation of liver metastases from small intestinal neuroendocrine tumours.
Norlén O; Stålberg P; Zedenius J; Hellman P
Br J Surg; 2013 Oct; 100(11):1505-14. PubMed ID: 24037573
[TBL] [Abstract][Full Text] [Related]
20. Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery.
Jaeck D; Oussoultzoglou E; Bachellier P; Lemarque P; Weber JC; Nakano H; Wolf P
World J Surg; 2001 Jun; 25(6):689-92. PubMed ID: 11376398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
